Nypro to establish a Medical Device Manufacturing facility in Waterford creating over 200 new jobs

Nypro’s new facility will manufacture advanced respiratory and injectable devices for global healthcare and pharmaceutical customers. Among the new positions to becreated are healthcare automation engineers and technicians, healthcare quality engineers and technicians, operations managers, program managers, team leaders and operators.

An Taoiseach Enda Kenny TD said, “I welcome the decision by Nypro to establish a new medical device manufacturing facility in Waterford with the creation of over 200 highly skilled jobs as it is a significant boon for the whole South East. The recent experience of Nypro – reinvention and refocusing on growing sectors, resonates with the wider Irish economy. Through the Government’s Action Plan for Jobs we are refocusing the entire economy back to exports, enterprise and innovation. As the transition of the economy continues there will be more job opportunities for Waterford and the South East. Nypro’s investment in Waterford is a massive vote of confidence for the region and will bring new, high-quality jobs.”

James O’ Gorman, Vice President, Drug Delivery and Diagnostics of Nypro Healthcare said, “Nypro Healthcare, a recognised leader in the development and manufacture of complex drug delivery and diagnostic devices, is delighted to announce the addition of a new facility in Ireland in Waterford. Nypro has operated in Ireland in Bray since 1980 and in recent years our healthcare business has grown significantly. Our latest growth phase is built upon the skills, work ethic, creativity and drive of our Nypro Ireland team. We now plan to create over 200 positions in Waterford to manufacture complex respiratory and injection devices for our pharmaceutical customers worldwide. I would like to thank Nypro Inc, the Irish Government, IDA, Waterford citycouncil, FAS and our Nypro Ireland team for their continued support and look forward to further growth of our Irish operations in future years.”

Barry O’Leary, CEO of IDA Ireland said, ‘’Today’s announcement by Nypro is excellent news for Ireland’s medical technologies sector and for the South East region. Nypro’s new facility, in a key regional location, is in the development and manufacture of drug delivery devices which are key target areas for IDA Ireland and will further add to Ireland’s growing expertise in these areas. The South East region is developing its position as a key location for the life-sciences sector.’’